BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20614090)

  • 1. Transmission Raman spectroscopy as a tool for quantifying polymorphic content of pharmaceutical formulations.
    Aina A; Hargreaves MD; Matousek P; Burley JC
    Analyst; 2010 Sep; 135(9):2328-33. PubMed ID: 20614090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive quantitative assessment of the content of pharmaceutical capsules using transmission Raman spectroscopy.
    Eliasson C; Macleod NA; Jayes LC; Clarke FC; Hammond SV; Smith MR; Matousek P
    J Pharm Biomed Anal; 2008 Jun; 47(2):221-9. PubMed ID: 18296001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative transmission Raman spectroscopy of pharmaceutical tablets and capsules.
    Johansson J; Sparén A; Svensson O; Folestad S; Claybourn M
    Appl Spectrosc; 2007 Nov; 61(11):1211-8. PubMed ID: 18028700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of pharmaceuticals via transmission Raman spectroscopy: data sub-selection.
    Burley JC; Aina A; Matousek P; Brignell C
    Analyst; 2014 Jan; 139(1):74-8. PubMed ID: 24223421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of transmission Raman spectroscopy for rapid quantitative analysis of intact multi-component pharmaceutical capsules.
    Hargreaves MD; Macleod NA; Smith MR; Andrews D; Hammond SV; Matousek P
    J Pharm Biomed Anal; 2011 Feb; 54(3):463-8. PubMed ID: 20947277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bulk Raman analysis of pharmaceutical tablets.
    Matousek P; Parker AW
    Appl Spectrosc; 2006 Dec; 60(12):1353-7. PubMed ID: 17217583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct, non-destructive quantitative measurement of an active pharmaceutical ingredient in an intact capsule formulation using Raman spectroscopy.
    Kim J; Noh J; Chung H; Woo YA; Kemper MS; Lee Y
    Anal Chim Acta; 2007 Aug; 598(2):280-5. PubMed ID: 17719903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of polymorphic impurity in an enantiotropic polymorph system using differential scanning calorimetry, X-ray powder diffraction and Raman spectroscopy.
    Li Y; Chow PS; Tan RB
    Int J Pharm; 2011 Aug; 415(1-2):110-8. PubMed ID: 21645601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of the transition temperature for an enantiotropic polymorphic system from the transformation kinetics monitored using Raman spectroscopy.
    Hu Y; Wikström H; Byrn SR; Taylor LS
    J Pharm Biomed Anal; 2007 Nov; 45(4):546-51. PubMed ID: 17851013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of sampling techniques for in-line monitoring using Raman spectroscopy.
    Wikström H; Lewis IR; Taylor LS
    Appl Spectrosc; 2005 Jul; 59(7):934-41. PubMed ID: 16053566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved understanding of factors contributing to quantification of anhydrate/hydrate powder mixtures.
    Rantanen J; Wikström H; Rhea FE; Taylor LS
    Appl Spectrosc; 2005 Jul; 59(7):942-51. PubMed ID: 16053567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid quantification of low level polymorph content in a solid dose form using transmission Raman spectroscopy.
    Griffen JA; Owen AW; Burley J; Taresco V; Matousek P
    J Pharm Biomed Anal; 2016 Sep; 128():35-45. PubMed ID: 27218440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the relative amounts of three crystal forms of a benzimidazole drug in complex finished formulations by FT-Raman spectroscopy.
    De Spiegeleer B; Seghers D; Wieme R; Schaubroeck J; Verpoort F; Slegers G; Van Vooren L
    J Pharm Biomed Anal; 2005 Sep; 39(1-2):275-80. PubMed ID: 16085143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raman spectroscopic method for the determination of medroxyprogesterone acetate in a pharmaceutical suspension: validation of quantifying abilities, uncertainty assessment and comparison with the high performance liquid chromatography reference method.
    De Beer TR; Baeyens WR; Vermeire A; Broes D; Remon JP; Vervaet C
    Anal Chim Acta; 2007 Apr; 589(2):192-9. PubMed ID: 17418181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lean Raman imaging for rapid assessment of homogeneity in pharmaceutical formulations.
    Brown SC; Claybourn M; Sievwright D; Fearnside V; Ashman C
    Appl Spectrosc; 2010 Apr; 64(4):442-7. PubMed ID: 20412630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission Low-Frequency Raman Spectroscopy for Quantification of Crystalline Polymorphs in Pharmaceutical Tablets.
    Inoue M; Hisada H; Koide T; Fukami T; Roy A; Carriere J; Heyler R
    Anal Chem; 2019 Feb; 91(3):1997-2003. PubMed ID: 30606009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive authentication of pharmaceutical products through packaging using spatially offset Raman spectroscopy.
    Eliasson C; Matousek P
    Anal Chem; 2007 Feb; 79(4):1696-701. PubMed ID: 17297975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internal multiple-scattering hole-enhanced Raman spectroscopy: improved backscattering Fourier transform Raman sampling in pharmaceutical tablets utilizing cylindrical-conical holes.
    Larkin PJ; Santangelo M; Šašiċ S
    Appl Spectrosc; 2012 Aug; 66(8):892-902. PubMed ID: 22800376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of Raman spectroscopy to the analysis of phase transformations in pharmaceutical compounds.
    Hédoux A; Guinet Y; Descamps M
    Int J Pharm; 2011 Sep; 417(1-2):17-31. PubMed ID: 21256937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of spatial resolution and sensitivity in transmission and backscattering Raman spectroscopy of opaque samples: impact on pharmaceutical quality control and Raman tomography.
    Everall N; Priestnall I; Dallin P; Andrews J; Lewis I; Davis K; Owen H; George MW
    Appl Spectrosc; 2010 May; 64(5):476-84. PubMed ID: 20482965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.